In individual human tumor specimens, these principal components of the pathway—RB-CDK4/6-p16INK4A—are reported to be targeted in a mutually exclusive manner (Sherr and McCormick, 2002) consistent with their overlapping functions in regulating the G1-S transition of the cell cycle (Massague, 2004). Here, CDKN2A is linked to neoplasm.